UW Medicine to co-lead COVID-19 vaccine study – KIRO 7 News Seattle


The University of Washington School of Medicine, along with the Kaiser Permanente Center for Health Research in Portland, Oregon, will conduct a study on the effectiveness of the COVID-19 vaccine.

The study is now underway. Researchers are looking for nearly 3,500 children and adults to participate in the four-year study. During this period, vaccinated and unvaccinated participants will be monitored for any COVID-19 infection, COVID-like illness or other respiratory infections such as influenza. Dr. Helen Chu is an associate professor of medicine, who will co-lead the study. She says one of her main goals is to see how effective the vaccine is for children aged 5 to 18. She says this study will provide vital information in the continued fight against the virus.

“And then new variants will keep coming. And we’re going to see how these vaccines work,” Chu said.

“And also look at the effects of repeat vaccinations and boosters. To understand how long your immunity lasts and whether or not this is different over time and across age range in children and adults. Chu said.

Meanwhile, Chu says people will be tested weekly for the virus with home PCR tests. Children will have the test done by their parents and adults will take the test themselves. According to a press release from UW Medicine, participants will complete weekly symptom surveys online or by phone. Vaccinations will not be administered as part of the study.

“COVID is not going away. It’s going to be for a long time,” Chu said.

KIRO7 asked Chu if she thought the study could convince the unvaccinated to get vaccinated. She says she’s not sure that will be the case, but thinks the study will provide plenty of real data in the future.

“I’m not sure this will be the study that convinces a parent who isn’t going to vaccinate their child to get their child vaccinated, but it will provide real insight into vaccine performance,” Chu said.

“It will help us understand the questions about long COVID, about all these other things,” Chu said.

The study is funded by the US Centers for Disease Control and Prevention. To register to participate, click here.


About Author

Comments are closed.